SK284727B6 - Kompozícia obsahujúca granulát pozostávajúci z účinnej zložky, ktorá je rozpustná vo vode - Google Patents
Kompozícia obsahujúca granulát pozostávajúci z účinnej zložky, ktorá je rozpustná vo vode Download PDFInfo
- Publication number
- SK284727B6 SK284727B6 SK167-99A SK16799A SK284727B6 SK 284727 B6 SK284727 B6 SK 284727B6 SK 16799 A SK16799 A SK 16799A SK 284727 B6 SK284727 B6 SK 284727B6
- Authority
- SK
- Slovakia
- Prior art keywords
- granulate
- water
- active ingredient
- soluble
- weight
- Prior art date
Links
- 239000008187 granular material Substances 0.000 title claims abstract description 53
- 239000004480 active ingredient Substances 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 235000010980 cellulose Nutrition 0.000 claims abstract description 21
- 229920002678 cellulose Polymers 0.000 claims abstract description 21
- 239000001913 cellulose Substances 0.000 claims abstract description 20
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 19
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 19
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 19
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 17
- 238000005550 wet granulation Methods 0.000 claims abstract description 16
- 239000011230 binding agent Substances 0.000 claims abstract description 14
- 239000007884 disintegrant Substances 0.000 claims abstract description 12
- 230000008569 process Effects 0.000 claims abstract description 10
- 239000007864 aqueous solution Substances 0.000 claims abstract description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 6
- 238000007873 sieving Methods 0.000 claims description 4
- 239000000470 constituent Substances 0.000 claims description 2
- 238000012216 screening Methods 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 33
- 150000001875 compounds Chemical class 0.000 description 18
- 239000007788 liquid Substances 0.000 description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 239000002552 dosage form Substances 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- 229940079593 drug Drugs 0.000 description 10
- 239000013543 active substance Substances 0.000 description 8
- 238000005469 granulation Methods 0.000 description 8
- 230000003179 granulation Effects 0.000 description 8
- 235000010323 ascorbic acid Nutrition 0.000 description 7
- 229960005070 ascorbic acid Drugs 0.000 description 7
- 239000011668 ascorbic acid Substances 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- HCTVWSOKIJULET-LQDWTQKMSA-M phenoxymethylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 HCTVWSOKIJULET-LQDWTQKMSA-M 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 229940032147 starch Drugs 0.000 description 5
- 239000003643 water by type Substances 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 235000013924 ferrous gluconate Nutrition 0.000 description 3
- 239000004222 ferrous gluconate Substances 0.000 description 3
- 229960001645 ferrous gluconate Drugs 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920003134 Eudragit® polymer Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229960004308 acetylcysteine Drugs 0.000 description 2
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229950008138 carmellose Drugs 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000007922 dissolution test Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- -1 for example Natural products 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000006186 oral dosage form Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000007916 tablet composition Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 229960000344 thiamine hydrochloride Drugs 0.000 description 2
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 2
- 239000011747 thiamine hydrochloride Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000220479 Acacia Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010011684 Cutaneous tuberculosis Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- CZNVSLGYWMSMKE-OPDGVEILSA-K Ferric gluconate Chemical compound [Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O CZNVSLGYWMSMKE-OPDGVEILSA-K 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical class C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 1
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 description 1
- 206010044725 Tuberculid Diseases 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 229960004273 floxacillin Drugs 0.000 description 1
- PARMJFIQRZRMHG-VICXVTCVSA-M flucloxacillin sodium monohydrate Chemical compound O.[Na+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl PARMJFIQRZRMHG-VICXVTCVSA-M 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 229940066491 mucolytics Drugs 0.000 description 1
- 229940053050 neomycin sulfate Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- NONJJLVGHLVQQM-JHXYUMNGSA-N phenethicillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C(C)OC1=CC=CC=C1 NONJJLVGHLVQQM-JHXYUMNGSA-N 0.000 description 1
- 229960004894 pheneticillin Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 102220289725 rs778831047 Human genes 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 229940023144 sodium glycolate Drugs 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- LFBBSWBQNQXKPF-LQDWTQKMSA-M sodium;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 LFBBSWBQNQXKPF-LQDWTQKMSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- JEJAMASKDTUEBZ-UHFFFAOYSA-N tris(1,1,3-tribromo-2,2-dimethylpropyl) phosphate Chemical compound BrCC(C)(C)C(Br)(Br)OP(=O)(OC(Br)(Br)C(C)(C)CBr)OC(Br)(Br)C(C)(C)CBr JEJAMASKDTUEBZ-UHFFFAOYSA-N 0.000 description 1
- 230000001549 tubercolostatic effect Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Glanulating (AREA)
- Jellies, Jams, And Syrups (AREA)
- General Preparation And Processing Of Foods (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96202289 | 1996-08-14 | ||
| PCT/EP1997/004570 WO1998006382A1 (en) | 1996-08-14 | 1997-08-14 | Granulates comprising a water soluble compound and cellulose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK16799A3 SK16799A3 (en) | 1999-07-12 |
| SK284727B6 true SK284727B6 (sk) | 2005-10-06 |
Family
ID=8224290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK167-99A SK284727B6 (sk) | 1996-08-14 | 1997-08-14 | Kompozícia obsahujúca granulát pozostávajúci z účinnej zložky, ktorá je rozpustná vo vode |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0948318B1 (cs) |
| JP (1) | JP2000516601A (cs) |
| CN (1) | CN1139377C (cs) |
| AT (1) | ATE262318T1 (cs) |
| AU (1) | AU4618097A (cs) |
| BG (1) | BG64455B1 (cs) |
| BR (1) | BR9711148A (cs) |
| CA (1) | CA2264105C (cs) |
| CZ (1) | CZ49099A3 (cs) |
| DE (1) | DE69728290T2 (cs) |
| DK (1) | DK0948318T3 (cs) |
| EA (1) | EA002811B1 (cs) |
| ES (1) | ES2218702T3 (cs) |
| NO (1) | NO990665L (cs) |
| PL (1) | PL192959B1 (cs) |
| PT (1) | PT948318E (cs) |
| SI (1) | SI0948318T1 (cs) |
| SK (1) | SK284727B6 (cs) |
| TR (1) | TR199900296T2 (cs) |
| WO (1) | WO1998006382A1 (cs) |
| ZA (1) | ZA977316B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465009B1 (en) * | 1998-03-18 | 2002-10-15 | Yamanouchi Pharmaceutical Co., Ltd. | Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
| ES2179729B1 (es) * | 2000-03-23 | 2003-12-16 | Dreiman Lab Farmaceuticos S A | Forma farmaceutica solida de administracion oral dispersable en agua, que comprende rifampicina, isoniazida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica. |
| JP4698000B2 (ja) * | 2000-06-27 | 2011-06-08 | 旭化成ケミカルズ株式会社 | 水易溶性薬物含有錠剤 |
| JP4547161B2 (ja) * | 2004-01-22 | 2010-09-22 | エスエス製薬株式会社 | 用時溶解型速溶性固形製剤 |
| JP3996626B2 (ja) * | 2004-06-22 | 2007-10-24 | 塩野義製薬株式会社 | 口腔内速崩壊錠 |
| JP5198001B2 (ja) * | 2006-06-23 | 2013-05-15 | 武田薬品工業株式会社 | 安定化された固形製剤 |
| EP2042164A4 (en) * | 2006-06-23 | 2010-10-13 | Takeda Pharmaceutical | STABILIZED SOLID PREPARATION |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5049394A (en) * | 1987-09-11 | 1991-09-17 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition containing high drug load and method for preparing same |
| DE68916983T2 (de) * | 1988-02-25 | 1995-01-19 | Yamanouchi Europ Bv | Verfahren zur Herstellung eines pharmazeutischen Granulats. |
| JP2628230B2 (ja) * | 1991-12-30 | 1997-07-09 | エフ エム シー コーポレーション | 微結晶性セルローススフェロニゼーション組成物 |
-
1997
- 1997-08-14 TR TR1999/00296T patent/TR199900296T2/xx unknown
- 1997-08-14 ES ES97944780T patent/ES2218702T3/es not_active Expired - Lifetime
- 1997-08-14 CN CNB971972672A patent/CN1139377C/zh not_active Expired - Fee Related
- 1997-08-14 CZ CZ99490A patent/CZ49099A3/cs unknown
- 1997-08-14 JP JP10509421A patent/JP2000516601A/ja not_active Ceased
- 1997-08-14 PL PL331588A patent/PL192959B1/pl not_active IP Right Cessation
- 1997-08-14 DK DK97944780T patent/DK0948318T3/da active
- 1997-08-14 PT PT97944780T patent/PT948318E/pt unknown
- 1997-08-14 AU AU46180/97A patent/AU4618097A/en not_active Abandoned
- 1997-08-14 DE DE69728290T patent/DE69728290T2/de not_active Expired - Fee Related
- 1997-08-14 WO PCT/EP1997/004570 patent/WO1998006382A1/en not_active Ceased
- 1997-08-14 SI SI9730650T patent/SI0948318T1/xx unknown
- 1997-08-14 ZA ZA977316A patent/ZA977316B/xx unknown
- 1997-08-14 CA CA002264105A patent/CA2264105C/en not_active Expired - Fee Related
- 1997-08-14 SK SK167-99A patent/SK284727B6/sk unknown
- 1997-08-14 EP EP97944780A patent/EP0948318B1/en not_active Expired - Lifetime
- 1997-08-14 EA EA199900193A patent/EA002811B1/ru unknown
- 1997-08-14 BR BR9711148A patent/BR9711148A/pt active Search and Examination
- 1997-08-14 AT AT97944780T patent/ATE262318T1/de not_active IP Right Cessation
-
1999
- 1999-02-12 BG BG103175A patent/BG64455B1/bg unknown
- 1999-02-12 NO NO990665A patent/NO990665L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI0948318T1 (en) | 2004-08-31 |
| NO990665L (no) | 1999-04-12 |
| CZ49099A3 (cs) | 1999-06-16 |
| SK16799A3 (en) | 1999-07-12 |
| BG103175A (en) | 1999-08-31 |
| PT948318E (pt) | 2004-06-30 |
| CA2264105A1 (en) | 1998-02-19 |
| BR9711148A (pt) | 1999-08-17 |
| CN1139377C (zh) | 2004-02-25 |
| DE69728290T2 (de) | 2004-08-05 |
| CA2264105C (en) | 2007-04-24 |
| BG64455B1 (bg) | 2005-03-31 |
| WO1998006382A1 (en) | 1998-02-19 |
| CN1228019A (zh) | 1999-09-08 |
| EP0948318B1 (en) | 2004-03-24 |
| DE69728290D1 (de) | 2004-04-29 |
| ATE262318T1 (de) | 2004-04-15 |
| EA199900193A1 (ru) | 1999-10-28 |
| EP0948318A1 (en) | 1999-10-13 |
| TR199900296T2 (xx) | 1999-06-21 |
| JP2000516601A (ja) | 2000-12-12 |
| NO990665D0 (no) | 1999-02-12 |
| ZA977316B (en) | 1999-02-15 |
| ES2218702T3 (es) | 2004-11-16 |
| AU4618097A (en) | 1998-03-06 |
| PL331588A1 (en) | 1999-07-19 |
| DK0948318T3 (da) | 2004-06-28 |
| PL192959B1 (pl) | 2006-12-29 |
| EA002811B1 (ru) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1341527B1 (en) | Pharmaceutical preparation comprising an active dispersed on a matrix | |
| US20030215504A1 (en) | Directly compressible acetaminophen compositions | |
| JP2001526212A (ja) | 咀嚼分散性錠剤の製造法 | |
| US20040197402A1 (en) | Oxcarbazepine dosage forms | |
| SK176798A3 (en) | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug | |
| SK287322B6 (sk) | Spôsob výroby poťahovaných granúl s maskovanou chuťou a okamžitým uvoľňovaním účinnej zložky | |
| US5948422A (en) | Oral dosage-forms containing a β-lactam antibiotic | |
| SK9832002A3 (en) | Glyburide composition | |
| JP2006514968A (ja) | 低減された苦味を有する製薬組成物 | |
| WO2018167589A1 (en) | Pharmaceutical composition comprising dapagliflozin | |
| US20070219250A1 (en) | Pharmaceutical Compositions of Nateglinide | |
| SK284727B6 (sk) | Kompozícia obsahujúca granulát pozostávajúci z účinnej zložky, ktorá je rozpustná vo vode | |
| KR101060885B1 (ko) | 염산 베니디핀 함유 의약 조성물 | |
| JPH08310969A (ja) | 固形薬品組成物及びその製造方法 | |
| US8062664B2 (en) | Process for preparing formulations of lipid-regulating drugs | |
| WO2006109175A2 (en) | Solid dosage form of an antidiabetic drug | |
| WO1999020277A1 (en) | Rapidly soluble drug composition | |
| MXPA99001493A (es) | Granulados que comprenden un compuesto soluble en agua y celulosa | |
| AU2005203095A1 (en) | Granulates comprising a water soluble compound and cellulose | |
| HUP9903127A2 (hu) | Vízoldható vegyületet és cellulózt tartalmazó granulátumok | |
| CA2531097C (en) | Process for preparing formulations of lipid-regulating drugs | |
| EP2257278A1 (en) | Oral tablet compositions containing nateglinide and surfactan ph adjusting agent | |
| US20060177512A1 (en) | Process for preparing formulations of lipid-regulating drugs | |
| AU2002302888A1 (en) | Oxcarbazepine dosage forms |